KR102531788B1 - Oral composition and method for inhibiting discoloration thereof - Google Patents

Oral composition and method for inhibiting discoloration thereof Download PDF

Info

Publication number
KR102531788B1
KR102531788B1 KR1020180112642A KR20180112642A KR102531788B1 KR 102531788 B1 KR102531788 B1 KR 102531788B1 KR 1020180112642 A KR1020180112642 A KR 1020180112642A KR 20180112642 A KR20180112642 A KR 20180112642A KR 102531788 B1 KR102531788 B1 KR 102531788B1
Authority
KR
South Korea
Prior art keywords
composition
component
discoloration
oral cavity
mass
Prior art date
Application number
KR1020180112642A
Other languages
Korean (ko)
Other versions
KR20190076829A (en
Inventor
케이지 이시구로
고우타로우 이이즈미
Original Assignee
라이온 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이온 가부시키가이샤 filed Critical 라이온 가부시키가이샤
Publication of KR20190076829A publication Critical patent/KR20190076829A/en
Application granted granted Critical
Publication of KR102531788B1 publication Critical patent/KR102531788B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/411Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives

Abstract

고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 주는 트라넥삼산 함유의 구강용 조성물 및 그 변색 억제 방법을 제공한다.
(A) 트라넥삼산, (B) 카티온화셀룰로스 및 (C) 차엑기스를 함유하고, [(A)+(B)]/(C)가 질량비로서 0.5∼200, 또한 (B)/(C)가 질량비로서 0.2∼100인 것을 특징으로 하는 구강용 조성물, 또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 이상을 함유하는 상기 구강용 조성물 및 상기 (A) 및 (B)성분을 배합한 구강용 조성물에, (C)성분을 배합하고, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비를 각각 상기 범위로 하는 것을 특징으로 하는, 상기 구강용 조성물의 변색 억제 방법.
Provided is an oral composition containing tranexamic acid that suppresses discoloration of formulations even after storage at a high temperature and provides excellent external appearance stability, and a method for suppressing discoloration thereof.
(A) contains tranexamic acid, (B) cationized cellulose, and (C) tea extract, [(A)+(B)]/(C) is 0.5 to 200 as a mass ratio, and further (B)/(C) ) is a composition for oral cavity characterized in that the mass ratio is 0.2 to 100, and (D) the composition for oral cavity containing at least one selected from 3-octanol, 3-octyl acetate, 3-octanone and pencon. And to the composition for oral cavity containing the above (A) and (B) components, (C) component is blended, and the mass ratio of [(A) + (B)] / (C) and (B) / (C) Discoloration suppression method of the said composition for oral cavity characterized by making mass ratio into the said range, respectively.

Description

구강용 조성물 및 그 변색 억제 방법{ORAL COMPOSITION AND METHOD FOR INHIBITING DISCOLORATION THEREOF}Oral composition and method for inhibiting discoloration thereof {ORAL COMPOSITION AND METHOD FOR INHIBITING DISCOLORATION THEREOF}

본 발명은, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 갖는 트라넥삼산 함유의 구강용 조성물 및 그 변색 억제 방법에 관한 것이다.The present invention relates to a composition for oral use containing tranexamic acid that suppresses discoloration of a formulation even after storage at a high temperature and has excellent external appearance stability, and a method for suppressing discoloration thereof.

트라넥삼산은, 잇몸의 항염증 효과가 있는 기능 성분이고, 치주병 예방 성분으로서 구강용 조성물에 배합되고(특허 문헌 1 ; 일본 특개2009-149565호 공보), 치마제 조성물에 배합한 트라넥삼산의 구강 내 체류성을 개선하여 효과를 향상하기 위해 히드록시에틸셀룰로스·디메틸디알릴암모늄염이 효과를 이루는 것이, 특허 문헌 2(일본 특개2001-226244호 공보)에 제안되어 있다.Tranexamic acid is a functional component having an anti-inflammatory effect on the gums, and is blended into oral compositions as a periodontal disease preventive component (Patent Document 1; Japanese Unexamined Patent Publication No. 2009-149565), and tranexamic acid blended into dentifrice compositions It is proposed in Patent Document 2 (Japanese Patent Laid-Open No. 2001-226244) that hydroxyethyl cellulose-dimethyldiallylammonium salt achieves an effect in order to improve the retention in the oral cavity and improve the effect.

또한, 트라넥삼산은, 구강용 조성물의 사용감 개선에 응용할 수 있는 것이 특허 문헌 3, 4(일본 특개2008-143870호 공보, 일본 특개소60-130509호 공보)에 제안되어 있다.In addition, patent documents 3 and 4 (Japanese Unexamined Patent Publication Nos. 2008-143870 and 60-130509) suggest that tranexamic acid can be applied to improve the feeling of use of oral compositions.

그렇지만, 트라넥삼산은, 배합 성분에 의해서는 경시에서 제제 변색을 초래하는 일이 있다는 문제가 있다. 변색을 억제하는 기술은, 특허 문헌 5, 6(일본 특허 제4656299호 공보, 일본 특허 제5842565호 공보)에 제안되어 있고, 특허 문헌 6에서는, 세구제에 트라넥삼산과 향료 성분인 신나믹알데히드를 병용하여 배합함으로써 생기는 경시에서의 제제 변색의 억제에, 라우릴황산나트륨을 특정량 배합하여 외관 안정성을 개선하고 있다.However, tranexamic acid has a problem that it may cause discoloration of the formulation over time depending on the ingredients. Techniques for suppressing discoloration are proposed in Patent Documents 5 and 6 (Japanese Patent No. 4656299 and Japanese Patent No. 5842565), and in Patent Document 6, tranexamic acid and cinnamic aldehyde, which is a fragrance ingredient, are used in mouthwash. In order to suppress the discoloration of the formulation over time caused by blending together, a specific amount of sodium lauryl sulfate is blended to improve the external appearance stability.

특허 문헌 1 : 일본 특개2009-149565호 공보Patent Document 1: Japanese Patent Laid-Open No. 2009-149565 특허 문헌 2 : 일본 특개2001-226244호 공보Patent Document 2: Japanese Patent Laid-Open No. 2001-226244 특허 문헌 3 : 일본 특개2008-143870호 공보Patent Document 3: Japanese Patent Laid-Open No. 2008-143870 특허 문헌 4 : 일본 특개소60-130509호 공보Patent Document 4: Japanese Patent Laid-Open No. 60-130509 특허 문헌 5 : 일본 특허 제4656299호 공보Patent Document 5: Japanese Patent No. 4656299 특허 문헌 6 : 일본 특허 제5842565호 공보Patent Document 6: Japanese Patent No. 5842565

본 발명은 상기 사정을 감안하여 이루어진 것으로, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 주는 트라넥삼산 함유의 구강용 조성물 및 그 변색 억제 방법을 제공하는 것을 목적으로 한다.The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a composition for oral use containing tranexamic acid that suppresses discoloration of formulations even after storage at a high temperature and gives excellent external appearance stability, and a method for suppressing discoloration thereof.

본 발명자들은, 상기 목적을 달성하기 위해 예의 검토를 행한 결과, 구강용 조성물에 트라넥삼산과 카티온화셀룰로스를 배합한 때에 생기는 제제 변색의 억제에, 차엑기스를 특정 비율로 배합하는 것이 유효한 것을 지견하였다. 즉, 본 발명에서는, (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비가 각각 특정 범위 내인 것에 의해, 고온 보존 후에도 제제 변색이 억제되고, 우수한 외관 안정성을 주고, 또한, 불쾌한 맛이 억제되어 맛이 좋은 사용감을 주는 구강용 조성물을 제공할 수 있는 것을 지견하여, 본 발명을 이루는데 이르렀다.As a result of intensive studies to achieve the above object, the inventors of the present invention have found that blending a tea extract in a specific ratio is effective for inhibiting discoloration of the formulation that occurs when tranexamic acid and cationized cellulose are blended into an oral composition. did That is, in the present invention, (A) a composition for oral cavity containing tranexamic acid and (B) cationized cellulose is blended with (C) tea extract, and [(A)+(B)]/(C) When the mass ratio and the mass ratio of (B)/(C) are within a specific range, discoloration of the formulation is suppressed even after storage at high temperature, excellent external appearance stability is given, and an unpleasant taste is suppressed to give a pleasant feeling of use. Oral composition It was found that it was possible to provide, and came to achieve the present invention.

더욱 상세히 기술하면, 상술한 바와 같이, 치마제 조성물에서의 트라넥삼산의 구강 내 체류성의 향상에 카티온화셀룰로스의 히드록시에틸셀룰로스·디메틸디알릴암모늄염이 유효한 것은 알려져 있지(특허 문헌 2)만, 본 발명자들이, (A) 트라넥삼산에, 구강 내 체류성을 개선하기 위해 (B) 카티온화셀룰로스를 병용하여 구강용 조성물에 배합한 바, 고온 보존 후에 갈변이 발생하여 제제가 변색한다는 과제가 생기고, 게다가, 상기한 갈변에 의한 제제 변색은, 셀룰로스 유도체라도 카르복시메틸셀룰로스나트륨을 사용한 때에는 인정되지 않고, (A) 및 (B)성분을 병용한 때에 생기는 독특한 과제인 것도 알았다. 그래서 본 발명자들은, 이러한 과제를 해결하기 위해 검토를 진행한 결과, (A) 및 (B)성분의 병용계에 (C)성분을 조합시키면, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비가 각각 특정 범위 내에서 (C)성분이 특이적으로 작용하여, 상기 병용계에 의한 제제 변색이 억제되고, 이에 의해, 고온 보존 후도 제제 변색이 억제되어 우수한 외관 안정성을 줄 수가 있었다. 또한, 이 경우, (A) 및 (B)성분을 병용하면 사용 후의 구강 내에 독특한 불쾌한 맛이 남는 일이 있지만, 이 불쾌한 맛의 뒷맛도 (C)성분에 의해 개선하고, 상기 각별히 현저한 작용 효과를 부여할 수 있었다.More specifically, as described above, it is known that hydroxyethylcellulose-dimethyldiallylammonium salt of cationized cellulose is effective in improving the retention of tranexamic acid in the oral cavity in the dentifrice composition (Patent Document 2), When the present inventors blended (A) tranexamic acid with (B) cationized cellulose in combination to improve oral retention in a composition for oral cavity, browning occurs after storage at high temperature and the problem of discoloration of the formulation is In addition, it was also found that the discoloration of the formulation due to browning described above is not recognized when carboxymethylcellulose sodium is used even for a cellulose derivative, and is a unique problem that occurs when components (A) and (B) are used in combination. So, the inventors of the present invention, as a result of conducting examinations to solve these problems, when combining (C) component with the combined use system of (A) and (B) components, [(A) + (B)] / (C) Component (C) acts specifically within a specific range of the mass ratio of and the mass ratio of (B)/(C), so that discoloration of the formulation due to the combination system is suppressed, thereby preventing discoloration of the formulation even after storage at a high temperature. It was suppressed and could give excellent appearance stability. In this case, when components (A) and (B) are used together, a unique unpleasant taste may remain in the oral cavity after use. could be given

후술하는 비교례의 결과로부터도 분명한 바와 같이, 본 발명의 작용 효과는, (A), (B) 및 (C)성분을 조합시켜서 사용하여도, [(A)+(B)]/(C)의 질량비 및 (B)/(C)의 질량비의 어느 하나가 부적절하면 뒤떨어지고, 또한, (A) 및 (B)성분에, (C)성분에 대신하여, 차엑기스와 마찬가지로 항산화작용을 갖는 식물 추출물인 감초엑기스를 조합시켜서 사용한 경우에는, 뒤떨어지는 것이었다.As is clear from the results of comparative examples described later, the action and effect of the present invention are [(A)+(B)]/(C) even when components (A), (B) and (C) are used in combination. ) and if either of the mass ratios of (B)/(C) is inappropriate, it will be inferior, and in place of the (C) component in (A) and (B) components, it has an antioxidant action similar to that of tea extract. When used in combination with licorice extract, which is a plant extract, it was inferior.

또한, 특허 문헌 2의 치마제 조성물은, 트라넥삼산 및 아니온성 계면활성제와 함께 히드록시에틸셀룰로스·디메틸디알릴암모늄염과, 아네톨, 카르본, 시네올, 메틸살리실레이트, 오이게놀, 에틸부틸레이트 및 신나믹알데히드에서 선택되는 특정한 향료 성분을 함유하고, 트라넥삼산의 구강 내 체류성 및 보존 안정성(액 분리)이 향상하고 있다. 이에 대해, 본 발명의 (A), (B) 및 (C)성분을 함유하는 구강용 조성물은, 상기 특정한 향료 성분을 함유하지 않아도, (A)성분에 의한 제제 변색이 억제되어 고온 보존 후도 외관 안정성(변색)이 우수하고, 맛도 좋다.In addition, the dentifrice composition of Patent Document 2 contains tranexamic acid and an anionic surfactant together with hydroxyethylcellulose dimethyldiallylammonium salt, anethol, carbon, cineol, methyl salicylate, eugenol, It contains a specific flavor component selected from ethyl butyrate and cinnamic aldehyde, and the oral retention and storage stability (liquid separation) of tranexamic acid are improved. On the other hand, the composition for oral cavity containing the components (A), (B) and (C) of the present invention suppresses the discoloration of the preparation due to the component (A), even after storage at a high temperature, even if the above specific fragrance component is not contained. Excellent appearance stability (discoloration) and good taste.

따라서 본 발명은, 하기한 구강용 조성물 및 그 변색 억제 방법을 제공한다.Accordingly, the present invention provides the composition for oral cavity described below and a method for suppressing discoloration thereof.

[1] (A) 트라넥삼산,[1] (A) tranexamic acid;

(B) 카티온화셀룰로스 및(B) cationized cellulose and

(C) 차엑기스를 함유하고, [(A)+(B)]/(C)가 질량비로서 0.5∼200, 또한 (B)/(C)가 질량비로서 0.2∼100인 것을 특징으로 하는 구강용 조성물.(C) contains tea extract, [(A)+(B)]/(C) is 0.5 to 200 as a mass ratio, and (B)/(C) is a mass ratio of 0.2 to 100, characterized in that for oral use composition.

[2] (B) 카티온화셀룰로스가, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드인 [1]에 기재된 구강용 조성물.[2] The composition for oral cavity according to [1], wherein (B) cationized cellulose is hydroxyethyl cellulose dimethyldiallylammonium chloride.

[3] (A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량% 함유하는 [1] 또는 [2]에 기재된 구강용 조성물.[3] The oral cavity according to [1] or [2], containing 0.01 to 0.2% by mass of component (A), 0.01 to 0.2% by mass of component (B), and 0.0005 to 0.2% by mass of component (C) as pure extract. composition for.

[4] 또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 이상을 0.0001∼0.1질량% 함유하는 [1]∼[3]의 어느 하나에 기재된 구강용 조성물.[4] Further, (D) any one of [1] to [3], containing 0.0001 to 0.1% by mass of at least one selected from 3-octanol, 3-octyl acetate, 3-octanone, and pencon. Compositions for oral use.

[5] 치마제 또는 세구제인 [1]∼[4]의 어느 하나에 기재된 구강용 조성물.[5] The composition for oral cavity according to any one of [1] to [4], which is a dentifrice or mouthwash.

[6] (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 하는, 상기 구강용 조성물의 변색 억제 방법.[6] A composition for oral cavity containing (A) tranexamic acid and (B) cationized cellulose was mixed with (C) tea extract, and [(A) + (B)]/(C) was used as a mass ratio of 0.5 to 200, and (B)/(C) as a mass ratio of 0.2 to 100.

[7] (A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 엑기스 순분으로서 0.0005∼0.2질량%배합하는, [6]에 기재된 상기 구강용 조성물의 변색 억제 방법.[7] The oral composition according to [6], comprising 0.01 to 0.2% by mass of component (A), 0.01 to 0.2% by mass of component (B), and 0.0005 to 0.2% by mass of component (C) as pure extract. Discoloration inhibition method of

본 발명에 의하면, 고온 보존 후도 제제 변색이 억제되고, 우수한 외관 안정성을 주고, 또한, 불쾌한 맛이 억제되어 맛이 좋은 사용감을 주는 트라넥삼산 함유의 구강용 조성물을 제공할 수 있다. 본 발명의 구강용 조성물은, 트라넥삼산의 구강 내 체류성도 좋고, 항염증 효과를 기대할 수 있는 것이어서 치육염을 억제하는 잇몸 케어용으로 적합하다.According to the present invention, it is possible to provide an oral composition containing tranexamic acid that suppresses discoloration of the formulation even after storage at a high temperature, gives excellent external appearance stability, and suppresses an unpleasant taste to give a pleasant feeling of use. The composition for oral cavity of the present invention has good retention of tranexamic acid in the oral cavity and anti-inflammatory effect can be expected, so it is suitable for gum care for suppressing gingivitis.

이하, 본 발명에 대해 더욱 상세히 기술한다. 본 발명의 구강용 조성물은, (A) 트라넥삼산, (B) 카티온화셀룰로스 및 (C) 차엑기스를 함유한다.Hereinafter, the present invention will be described in more detail. The composition for oral cavity of this invention contains (A) tranexamic acid, (B) cationized cellulose, and (C) tea extract.

(A) 트라넥삼산은, 유효 성분이고, 항염증 작용을 갖는다. (A) 트라넥삼산의 배합량은, 조성물 전체의 0.01∼0.2%(질량%, 이하 마찬가지)가 바람직하고, 특히 항염증 효과 및 변색 억제의 점에서 0.03∼0.1%가 보다 바람직하다. 이 범위 내이면, 제제 변색이 충분히 억제되고, 또한, 불쾌한 맛을 충분히 개선한다.(A) Tranexamic acid is an active ingredient and has an anti-inflammatory action. (A) The blending amount of tranexamic acid is preferably 0.01 to 0.2% (% by mass, the same applies below) of the total composition, and more preferably 0.03 to 0.1% in terms of anti-inflammatory effect and discoloration inhibition. Within this range, discoloration of the formulation is sufficiently suppressed, and unpleasant taste is sufficiently improved.

(B) 카티온화셀룰로스는, (A)성분의 구강 내 체류성을 향상하는 작용을 갖는다. (B) 카티온화셀룰로스로서는, 카티온기로서 디메틸디알릴암모늄, 2-히드록시-3(트리메틸암모니오)프로필 등을, 셀룰로스 유도체에 부가한 것 등을 들 수 있다. 예를 들면, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드, 염화O-[2-히드록시-3-(트리메틸암모니오)프로필]히드록시에틸셀룰로스 등이다. 질소 함유량은 0.1∼3%가 바람직하고, 보다 바람직하게는 0.5∼2. 5%이다.(B) Cationized cellulose has an effect of improving the retention of the component (A) in the oral cavity. (B) As cationized cellulose, what added dimethyldiallylammonium, 2-hydroxy-3 (trimethylammonio) propyl, etc. as a cation group to a cellulose derivative, etc. are mentioned. For example, hydroxyethyl cellulose dimethyl diallyl ammonium chloride, chloride O-[2-hydroxy-3-(trimethylammonio) propyl] hydroxyethyl cellulose, etc. are mentioned. The nitrogen content is preferably 0.1 to 3%, more preferably 0.5 to 2. 5%.

구체적으로 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드는, 히드록시에틸셀룰로스에 디메틸디알릴암모늄염을 그라프트 중합한 것이고, 2% 수용액의 점도가 10∼3,000mPa·s의 것(BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃)을 사용할 수 있다. 예를 들면, 악조노벨(주)제의 셀코트 L-200(2% 수용액 점도 : 35∼350mPa·s, BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃, 측정시간 1분), 셀코트 H-100(2% 수용액 점도 : 500∼2,750mPa·s, BH형 브룩필드 점도계, 로터 No. 2, 20회전, 21℃, 측정시간 1분) 등을 들 수 있다.Specifically, hydroxyethyl cellulose dimethyl diallyl ammonium chloride is obtained by graft polymerization of dimethyl diallyl ammonium salt on hydroxyethyl cellulose, and has a viscosity of 10 to 3,000 mPa s in a 2% aqueous solution (BH type Brookfield viscometer , Rotor No. 2, 20 rotations, 21°C) can be used. For example, Celcoat L-200 manufactured by Akzo Nobel Co., Ltd. (viscosity of 2% aqueous solution: 35 to 350 mPa s, BH type Brookfield viscometer, rotor No. 2, 20 rotations, 21 ° C., measurement time 1 minute) , Cellcoat H-100 (viscosity of 2% aqueous solution: 500 to 2,750 mPa·s, BH type Brookfield viscometer, rotor No. 2, 20 rotations, 21° C., measurement time 1 minute); and the like.

또한, 염화O-[2-히드록시-3-(트리메틸암모니오)프로필]히드록시에틸셀룰로스는, 1% 또는 2% 수용액으로 점도 측정을 할 수 있고, 1% 수용액의 점도가 500∼2,600mPa·s(BH형 브룩필드 점도계, 로터 No. 2, 20회전, 25℃)의 것, 또는 2% 수용액의 점도가 5∼800mPa·s의 것(BL형 점도계, 로터 No. 2, 30회전, 25℃)을 사용할 수 있다. 예를 들면, 라이온(주)제의 레오가드KGP(2% 수용액 점도 : 5∼50mPa·s), 레오가드G(2% 수용액 점도 : 100∼600mPa·s), 레오가드GP(2% 수용액 점도 : 100∼600mPa·s), 레오가드LP(2% 수용액 점도 : 300∼800mPa·s), 라이온(주)제의 레오가드MGP(1% 수용액 점도 : 500∼1, 200mPa·s), 레오가드㎖P(1% 수용액 점도 : 1,000∼2, 600mPa·s) 등을 들 수 있다.In addition, the viscosity of O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethyl cellulose chloride can be measured in 1% or 2% aqueous solution, and the viscosity of 1% aqueous solution is 500 to 2,600 mPa.・s (BH type Brookfield viscometer, rotor No. 2, 20 rotations, 25° C.), or a 2% aqueous solution having a viscosity of 5 to 800 mPa s (BL type viscometer, rotor No. 2, 30 rotations, 25° C.) can be used. For example, Leoguard KGP (2% aqueous solution viscosity: 5 to 50 mPa s) manufactured by Lion Co., Ltd., Leoguard G (2% aqueous solution viscosity: 100 to 600 mPa s), Leoguard GP (2% aqueous solution viscosity : 100 to 600 mPa s), Leoguard LP (2% aqueous solution viscosity: 300 to 800 mPa s), Lion Co., Ltd. Leoguard MGP (1% aqueous solution viscosity: 500 to 1,200 mPa s), Leo Guard mlP (viscosity of 1% aqueous solution: 1,000 to 2,600 mPa·s); and the like.

이들 카티온화셀룰로스 중에서도, 특히 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드가, (A) 트라넥삼산의 구강 내 체류 성향상의 점에서 알맞다.Among these cationized celluloses, hydroxyethyl cellulose dimethyl diallyl ammonium chloride (A) is preferable from the viewpoint of retention tendency of tranexamic acid in the oral cavity.

(B) 카티온화셀룰로스의 배합량은, 제제 변색 및 불쾌한 맛의 억제 효과의 점에서 조성물 전체의 0.01∼0.2%가 바람직하고, 0.03∼0.1%가 보다 바람직하다. 이 범위 내이면, 제제 변색이 충분히 억제되고, 또한, 불쾌한 맛이 충분히 개선한다. 0.2%를 초과하면, 그것 자신에 의한 불쾌한 맛이 강해져서 불쾌한 맛의 개선 효과가 충분히 얻어지지 않는 경우가 있다.(B) The blending amount of cationized cellulose is preferably 0.01 to 0.2%, more preferably 0.03 to 0.1% of the total composition, from the viewpoint of the effect of suppressing discoloration of the formulation and unpleasant taste. Within this range, discoloration of the formulation is sufficiently suppressed, and unpleasant taste is sufficiently improved. When it exceeds 0.2%, the unpleasant taste by itself becomes strong, and the improvement effect of an unpleasant taste may not fully be acquired.

본 발명에서는, (C) 차엑기스가, 제제 변색의 억제제로서 작용하고, 또한, 불쾌한 맛의 개선제로서도 작용한다.In the present invention, (C) tea extract acts as an inhibitor of discoloration of formulations and also acts as an unpleasant taste improver.

C) 차엑기스는, 시판품 또는 공지의 방법에 의해 얻어진 것을 사용할 수 있다. 구체적으로 원료는, 녹차를 사용할 수 있다. 추출 용매는 친수성 용매를 사용할 수 있고, 물이나, 에탄올, 프로판올 등의 저급 1가 알코올, 1,3-부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올 등의 친수성 용매를 들 수 있고, 이들에서 선택되는 1종의 단독 용매 또는 2종 이상의 혼합 용매를 사용할 수 있다. 추출 조건, 후처리는 통상의 방법을 채용할 수 있다.C) As tea extract, a commercial product or one obtained by a known method can be used. Specifically, green tea can be used as the raw material. A hydrophilic solvent may be used as the extraction solvent, and hydrophilic solvents such as water, lower monohydric alcohols such as ethanol and propanol, and polyhydric alcohols such as 1,3-butylene glycol and propylene glycol may be used. One single solvent or two or more mixed solvents may be used. Extraction conditions and post-processing can employ conventional methods.

시판품으로서는, 녹차 추출물(상품명 「화ism」, 엑기스분 0.2%, 용매 : 50%부틸렌글리콜 수용액, 마루젠제약(주)제) 등을 사용할 수 있다.As a commercial product, green tea extract (trade name "Hwaism", extract content 0.2%, solvent: 50% butylene glycol aqueous solution, manufactured by Maruzen Pharmaceutical Co., Ltd.) can be used.

(C) 차엑기스의 배합량은, 용매를 제외한 엑기스 순분으로서 조성물 전체의 0.0005∼0.2%가 바람직하고, 보다 바람직하게는 0.001∼0.1%이다. 0.0005% 이상이면, 제제 변색이 충분히 억제되어 우수한 외관 안정성을 얻을 수 있고, 또한, 불쾌한 맛이 충분히 억제되고, 맛이 개선한다. 0.2% 이하면, (C)성분 자신의 맛의 영향을 충분히 방지할 수 있다.(C) The blending amount of the tea extract is preferably 0.0005 to 0.2%, more preferably 0.001 to 0.1% of the total composition as pure extract excluding the solvent. When it is 0.0005% or more, discoloration of the formulation is sufficiently suppressed, excellent appearance stability can be obtained, and unpleasant taste is sufficiently suppressed and the taste is improved. If it is 0.2% or less, the influence of the taste of (C) component itself can fully be prevented.

본 발명에서 (A) 및 (B)성분의 배합량과 (C)성분의 배합량(용매를 제외한 엑기스 순분량)과의 비율을 나타내는 [(A)+(B)]/(C)는, 질량비로서 0.5∼200이고, 바람직하게는 1∼100이다. [(A)+(B)]/(C)의 질량비가 0.5 미만이면, (C)성분 자신의 맛에 의해 사용감이 손상되고, 200을 초과하면, 제제 변색의 억제 효과 및 불쾌한 맛의 개선 효과가 뒤떨어진다.In the present invention, [(A) + (B)] / (C), which represents the ratio between the blending amount of components (A) and (B) and the blending amount of component (C) (pure amount of extract excluding the solvent), is a mass ratio It is 0.5-200, Preferably it is 1-100. If the mass ratio of [(A) + (B)]/(C) is less than 0.5, the feeling of use is impaired due to the taste of the component (C) itself, and if it exceeds 200, the effect of suppressing discoloration of the formulation and the improvement of unpleasant taste falls behind

또한, (B)성분의 배합량과 (C)성분의 배합량(용매를 제외한 엑기스 순분량)과의 비율을 나타내는 (B)/(C)는, 질량비로서 0.2∼100이고, 바람직하게는 0.5∼50이다. (B)/(C)의 질량비가 0.2 미만이면, (C)성분 자신의 맛에 의해 사용감이 손상된다. 100을 초과하면, 불쾌한 맛의 개선 효과가 뒤떨어진다.In addition, (B)/(C), which represents the ratio between the compounding amount of component (B) and the compounding amount of component (C) (pure amount of extract excluding the solvent), is 0.2 to 100 as a mass ratio, preferably 0.5 to 50 am. (B) When the mass ratio of /(C) is less than 0.2, the feeling of use is impaired by the taste of the component (C) itself. When 100 is exceeded, the improvement effect of an unpleasant taste is inferior.

본 발명에서는, 또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 또는 2종 이상의 향료 성분을 배합하는 것이 바람직하다. (C)성분과 함께 (D)성분을 배합하면, 불쾌한 맛의 개선 효과가 높아지고, 불쾌한 맛의 뒷맛을 보다 개선할 수 있다. 또한, 옥탄올이라도, 치마제 조성물의 향료로서 일반적인 1-옥탄올은, 목적으로 하는 불쾌한 맛의 개선 효과가 만족하게 얻어지지 않는다. (D)성분은, 시판품을 사용할 수 있다. 예를 들면, 3-옥탄올은 시오노향료(주)제, 3-옥틸아세테이트 및 3-옥탄온은 각각 (주)이노우에 향료제조소제, 펜콘은 코에이흥업(주)제의 제품을 사용할 수 있다.In the present invention, it is also preferable to blend (D) one or two or more flavor components selected from 3-octanol, 3-octyl acetate, 3-octanone and pencon. When (D)component is mix|blended with (C)component, the improvement effect of an unpleasant taste will increase, and the unpleasant aftertaste can be improved more. In addition, even if it is octanol, 1-octanol which is common as a flavoring agent for a dentifrice composition cannot satisfactorily obtain the target unpleasant taste improvement effect. (D) A commercial item can be used for component. For example, 3-octanol is manufactured by Shiono Fragrance Co., Ltd., 3-octyl acetate and 3-octanone are manufactured by Inoue Fragrance Manufacturing Co., Ltd., and pencon is manufactured by Koei Hungup Co., Ltd. .

(D)성분의 배합량은, 0.0001∼0.1%가 바람직하고, 보다 바람직하게는 0.0001∼0.05%이다. 0.0001% 이상이면, 불쾌한 맛의 개선 효과가 충분히 향상한다. 0.1% 이하면, (D)성분 자체의 불쾌한 맛의 발현을 충분히 방지할 수 있다. (D)성분은, 총 배합량이 상기 범위 내인 것이 바람직하고, 이 범위 내에서 각 성분을 배합할 수 있다.(D) The blending amount of component is preferably 0.0001 to 0.1%, more preferably 0.0001 to 0.05%. When it is 0.0001% or more, the improvement effect of unpleasant taste is sufficiently improved. If it is 0.1% or less, expression of the unpleasant taste of (D) component itself can fully be prevented. It is preferable that the total compounding amount of (D)component is within the said range, and each component can be mix|blended within this range.

본 발명의 구강용 조성물은, 특히, 련치마, 액상치마, 윤제치마 등의 치마제, 특히 련치마나, 세구제로서 조제하는 것이 바람직하다. 또한, 상기 필수 성분에 더하여, 임의 성분으로서 제형 등에 응한 그 밖의 공지의 첨가제를, 본 발명의 효과를 방해하지 않는 범위에서 배합할 수 있다. 예를 들면 련치마인 경우는, 연마제, 점조제, 점결제, 계면활성제, 나아가서는 필요에 응하여 감미제, 방부제, 유효 성분, 착색제, 향료 등을 배합할 수 있고, 이들 성분과 물을 혼합하여 통상의 방법으로 제조할 수 있다. 세구제의 경우는, 점조제, 점결제, 계면활성제, 나아가서는 필요에 응하여 감미제, 방부제, 착색제, 향료, 유효 성분 등을 배합할 수 있다.The composition for oral cavity of the present invention is preferably prepared as a dentifrice such as a soft skirt, a liquid skirt, or a polished skirt, particularly a soft skirt, or a mouthwash. In addition to the above essential components, other known additives may be incorporated as optional components within a range that does not interfere with the effects of the present invention. For example, in the case of a soft skirt, an abrasive, a viscous agent, a binder, a surfactant, and furthermore, a sweetener, an antiseptic, an active ingredient, a colorant, a fragrance, etc. can be mixed as needed. can be produced in this way. In the case of mouthwash, viscous agents, binders, surfactants, and furthermore, sweeteners, preservatives, colorants, fragrances, active ingredients and the like can be blended as needed.

연마제로서는, 무수규산, 실리카겔, 알루미노실리케이트, 지르코노실리케이트 등의 실리카계 연마제, 제2인산칼슘2수화물, 제2인산칼슘무수화물, 제3인산칼슘, 제4인산칼슘, 제8인산칼슘, 피로인산칼슘, 수산화알루미늄, 알루미나, 2산화티탄, 결정성 지르코늄실리케이트, 폴리메틸메타아크릴레이트, 불용성 메타인산칼슘, 경질 탄산칼슘, 중질 탄산칼슘, 탄산마그네슘, 제3인산마그네슘, 제올라이트, 규산지르코늄, 하이드록시아파타이트, 플루오로아파타이트, 칼슘 결손 아파타이트, 합성수지계 연마제를 들 수 있다(배합량은 통상, 2∼50%, 특히 10∼40%).Examples of the abrasive include silica-based abrasives such as anhydrous silicic acid, silica gel, aluminosilicate, and zirconosilicate, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrate, tricalcium phosphate, quaternary calcium phosphate, octacalcium phosphate, Calcium pyrophosphate, aluminum hydroxide, alumina, titanium dioxide, crystalline zirconium silicate, polymethyl methacrylate, insoluble calcium metaphosphate, light calcium carbonate, heavy calcium carbonate, magnesium carbonate, tribasic magnesium phosphate, zeolite, zirconium silicate, hydroxyapatite, fluoroapatite, calcium-deficient apatite, and synthetic resin-based abrasives (the compounding amount is usually 2 to 50%, particularly 10 to 40%).

점조제로서는, 글리세린, 프로필렌글리콜, 평균분자량 200∼6,000(의약 부외품 원료 규격 2006 기재의 평균분자량)의 폴리에틸렌글리콜, 에틸렌글리콜 등의 다가 알코올, 소르비트, 환원전분당화물 등의 당알코올를 들 수 있고, 이들의 1종 또는 2종 이상을 사용할 수 있다(배합량은 통상, 5∼70%).Examples of the viscous agent include polyhydric alcohols such as glycerin, propylene glycol, polyethylene glycol having an average molecular weight of 200 to 6,000 (average molecular weight as described in Quasi-Drug Ingredients Standards 2006), ethylene glycol, and sugar alcohols such as sorbitol and reduced starch saccharide. These 1 type, or 2 or more types can be used (the compounding amount is 5 to 70% normally).

점결제로서는, 카티온화셀룰로스 이외의 것, 예를 들면 폴리아크릴산나트륨, 크산탄고무, 알긴산나트륨, 알긴산프로필렌글리콜에스테르, 카르복시메틸셀룰로스나트륨, 히드록시에틸셀룰로스, 카르보폴, 구아고무, 젤라틴, 아비셀 등의 유기 점결제, 몬모릴로나이트, 카올린, 벤토나이트 등의 무기 점결제를 들 수 있다(배합량은 통상, 0∼10%).Examples of binders other than cationized cellulose include sodium polyacrylate, xanthan gum, sodium alginate, propylene glycol alginate, carboxymethyl cellulose sodium, hydroxyethyl cellulose, carbopol, guar gum, gelatin, Avicel, etc. and inorganic binders such as montmorillonite, kaolin, and bentonite.

계면활성제는, 아니온성 계면활성제로서 예를 들면 라우릴황산나트륨, 라우로일살코신나트륨, 폴리옥시에틸렌알킬황산염, N-라우로일타우린염, α-올레핀술폰산염 등, 양성 계면활성제로서 예를 들면 N-아실글루타메이트, 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인, 야자유지방산아미드프로필베타인 등, 비이온성 계면활성제로서 예를 들면 알킬글리코시드, 자당지방산에스테르, 알킬올아마이드, 폴리옥시에틸렌소르비탄모노스테아레이트, 폴리옥시에틸렌폴리옥시프로필렌글리콜, 폴리옥시에틸렌알킬에테르, 라우린산데카글리세릴, 폴리옥시에틸렌경화피마자유 등을 들 수 있다(배합량은 통상, 0.1∼5%).The surfactant is an anionic surfactant, for example, sodium lauryl sulfate, sodium lauroyl sarcosine, polyoxyethylene alkyl sulfate, N-lauroyl taurine salt, α-olefin sulfonate, etc., as an amphoteric surfactant, for example Examples of nonionic surfactants such as N-acylglutamate, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, and coconut oil fatty acid amide propyl betaine include alkylglycosides, sucrose fatty acid esters, Alkylolamide, polyoxyethylene sorbitan monostearate, polyoxyethylene polyoxypropylene glycol, polyoxyethylene alkyl ether, decaglyceryl laurate, polyoxyethylene hydrogenated castor oil, etc. (the mixing amount is usually, 0.1-5%).

감미제로서는, 사카린트륨, 아스파르탐, 스테비오사이드, 스테비아엑기스, 파라메톡시신나믹알데히드, 네오헤스페리딘디히드로칼콘, 페릴라르틴, 방부제로서는, 에틸파라벤, 부틸파라벤 등의 파라벤(파라옥시안식향산에스테르), 안식향산나트륨을 들 수 있다. 착색제로서는, 청색1호, 황색4호, 녹색3호가 예시된다.Examples of sweeteners include saccharinthium, aspartame, stevioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidindihydrochalcone, perilartine, and preservatives, parabens such as ethylparaben and butylparaben (para-hydroxybenzoate). , sodium benzoate. As a coloring agent, Blue No. 1, Yellow No. 4, and Green No. 3 are illustrated.

향료는, (D)성분에 더하여, 그 밖의 치마제 조성물용으로서 일반적인 임의의 향료 성분을 배합할 수 있다. 향료로서는, 적어도 멘톨 및/또는 카르본을 포함한 향료가 바람직하고, 이들을 조성물 중에 0.01∼1%의 범위에서 함유하는 것이 바람직하다.In addition to the component (D), the fragrance can contain any general fragrance component for other dentifrice compositions. As the fragrance, a fragrance containing at least menthol and/or carbon is preferable, and it is preferable to contain these in the range of 0.01 to 1% in the composition.

유효 성분으로서는, 트라넥삼산 이외의 것, 예를 들면, 불화나트륨, 불화칼륨, 불화제1주석, 불화스트론튬, 모노플루오로인산나트륨 등의 불화물 ; 정인산의 칼륨염, 나트륨염등의 수용성 인산 화합물 ; 입실론-아미노카프론산, 알란토인클로르히드록시알미니움, 히노기티올, 아스코르빈산, 아세트산dl-토코페롤, 디히드로콜레스테롤, α-비사볼롤, 클로르헥시딘염류, 아줄렌, 글리시레틴, 글리시레틴산이나, 구리클로로필린나트륨, 클로로필, 글리세로포스페이트 등의 키레이트성 인산 화합물 ; 글루콘산구리 등의 구리 화합물 ; 염화스트론튬, 질산칼륨, 히드록삼산 또는 그 유도체, 트리폴리인산나트륨, 제올라이트, 메톡시에틸렌, 에피디히드로콜레스테린, 염화벤제토늄, 디히드로콜레스테롤, 트리클로로카르바닐리드, 구연산아연, 산화아연, 당위연(軟)엑기스, 황백엑기스, 나아가서는, 카밀레, 정자, 로즈마리, 황금, 홍화 등의 식물 추출물을 들 수 있다. 또한, 이들 유효 성분의 배합량은, 본 발명의 효과를 방해하지 않는 범위에서 유효량으로 할 수 있다.Examples of the active ingredient include fluorides other than tranexamic acid, such as sodium fluoride, potassium fluoride, stannous fluoride, strontium fluoride, and sodium monofluorophosphate; water-soluble phosphoric acid compounds such as potassium salt and sodium salt of orthophosphoric acid; Epsilon-aminocaproic acid, allantoin chlorhydroxyaluminium, hinogitiol, ascorbic acid, dl-tocopherol acetate, dihydrocholesterol, α-bisabolol, chlorhexidine salts, azulene, glycyrrhetin, glycyrrhetinic acid chelating phosphoric acid compounds such as sodium copper chlorophyllin, chlorophyll, and glycerophosphate; copper compounds such as copper gluconate; Strontium chloride, potassium nitrate, hydroxamic acid or its derivatives, sodium tripolyphosphate, zeolite, methoxyethylene, epidihydrocholesterin, benzethonium chloride, dihydrocholesterol, trichlorocarbanilide, zinc citrate, zinc oxide, sugar cane and plant extracts such as chamomile, sperm, rosemary, gold, and safflower. In addition, the compounding quantity of these active ingredients can be made into an effective amount within the range which does not impede the effect of this invention.

또한, 본 발명의 구강용 조성물의 변색 억제 방법은, (A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 한다. 또한, 배합 성분이나 그 배합량, 량비(量比) 등의 상세는, 상기한 바와 마찬가지이다.Further, the method for inhibiting discoloration of the composition for oral cavity of the present invention is to mix (C) tea extract with a composition for oral cavity in which (A) tranexamic acid and (B) cationized cellulose are blended, [(A)+( B)]/(C) as a mass ratio of 0.5 to 200, and (B)/(C) as a mass ratio of 0.2 to 100. In addition, details, such as a compounding component, its compounding quantity, and quantity ratio, are the same as those mentioned above.

[실시례][Example]

이하, 실시례 및 비교례를 나타내고, 본 발명을 구체적으로 설명하지만, 본 발명은 하기한 실시례로 제한되는 것이 아니다. 또한, 하기한 예에서 %는 특히 단서가 없는 한 모두 질량%를 나타낸다.Hereinafter, Examples and Comparative Examples will be shown and the present invention will be described in detail, but the present invention is not limited to the following Examples. Incidentally, in the following examples, all percentages represent mass % unless otherwise specified.

[실시례, 비교례][Examples, comparative examples]

표 1∼5에 표시하는 조성의 치마제(련치마) 또는 세구제를 일상 방법에 의해 조제하고, 이들을 시험 조성물로 하여 하기 방법으로 평가하였다. 결과를 표에 병기하였다.A dentifrice (soft skirt) or mouthwash having the composition shown in Tables 1 to 5 was prepared by a routine method, and these were used as test compositions and evaluated by the following method. The results were listed together in the table.

(1) 외관 안정성(변색 억제 효과)의 평가 방법(1) Evaluation method for appearance stability (discoloration inhibitory effect)

시험 조성물의 치마제는 라미네이트 튜브에, 세구제는 플라스틱 병에 충전하고, 제조 직후의 외관 및 50℃ 환경하에서 3개월간 보관 후의 외관을 각각 육안으로 확인하고, 하기한 평가 기준에 의거하여 변색에 관해 평가하였다. ○ 또는 ◎의 평가가 확보된 것을, 변색이 인정되지 않는 외관 안정성이 좋은 시험 조성물이라고 판단하였다.The dentifrice of the test composition was filled in a laminate tube and the dentifrice was filled in a plastic bottle, and the appearance immediately after manufacture and the appearance after storage for 3 months in a 50 ° C environment were visually checked, respectively, and based on the following evaluation criteria, regarding discoloration evaluated. What secured evaluation of ○ or ◎ was judged to be a test composition with good external appearance stability in which discoloration was not recognized.

평가 기준 :Evaluation standard :

◎ : 변색이 인정되지 않는다◎: Discoloration is not recognized

○ : 변색이 약간 인정되지만, 문제 없는 레벨이다○: Slight discoloration is recognized, but it is a problem-free level

△ : 변색이 인정된다△: Discoloration is recognized

× : 변색이 현저하게 인정된다.x: Discoloration is recognized notably.

(2) 불쾌한 맛의 뒷맛 없음(불쾌한 맛 개선 효과)의 평가 방법(2) Evaluation method for no unpleasant aftertaste (unpleasant taste improvement effect)

피험자로서 전문 패널러 10인을 이용하여 시험 조성물을 관능 평가하였다.The test composition was sensory evaluated using 10 expert panelists as subjects.

치마제는, 라미네이트 튜브에 충전한 치마제 조성물을 칫솔 위에 약 1g 압출하여 싣고, 평소와 같은 방법으로 3분간 이닦기하고, 또한, 세구제는, 약 10㎖을 약 20초간 입에 머금고, 토출하여 사용하였다. 사용하고 10분 경과 후의 입안에 남는 불쾌한 맛에 관해, 하기한 평점 기준에 의거하여 평가하였다.For the dentifrice, about 1 g of the dentifrice composition filled in the laminate tube is extruded on the toothbrush, brushed teeth in the same way as usual for 3 minutes, and the mouthwash is about 10 ml for about 20 seconds. and used it. The unpleasant taste remaining in the mouth after 10 minutes of use was evaluated based on the following rating criteria.

평점 기준 :Rating by:

1점 : 불쾌한 맛을 매우 느낀다1 point: Very unpleasant taste

2점 : 불쾌한 맛을 느낀다2 points: unpleasant taste

3점 : 불쾌한 맛을 약간 느끼지만, 문제 없는 레벨이다3 points: I feel a little unpleasant taste, but it is at a level that is not a problem.

4점 : 불쾌한 맛을 전혀 느끼지 않는다4 points: I do not feel any unpleasant taste

전문 패널러 10인이 평가한 결과를 평균한 값을 산출하고, 하기한 평가 기준에 의거하여 평가하였다. A value obtained by averaging the evaluation results of 10 professional panelists was calculated and evaluated based on the following evaluation criteria.

☆, ◎ 및 ○의 평가가 확보된 것을, 사용 후에 불쾌한 맛의 뒷맛이 느껴지지 않는 시험 조성물이라고 판단하였다.It was judged that what the evaluation of ☆, ◎, and ○ was secured was a test composition in which an unpleasant aftertaste was not felt after use.

평가 기준 :Evaluation standard :

☆ : 평균점 4점☆ : average score of 4 points

◎ : 평균점 3.5점 이상 4.0점 미만◎: average score of 3.5 or more and less than 4.0

○ : 평균점 3.0점 이상 3.5점 미만○: Average score of 3.0 or more and less than 3.5

△ : 평균점 2.0점 이상 3.0점 미만△: Average score of 2.0 or more and less than 3.0

× : 평균점 1.0점 이상 2.0점 미만×: average score of 1.0 or more and less than 2.0

사용 원료의 상세를 하기에 나타낸다.Details of the raw materials used are shown below.

(A) 트라넥삼산 : 시믹CMO(주)제(A) Tranexamic acid: manufactured by Simic CMO Co., Ltd.

(B) 카티온화셀룰로스 :(B) cationized cellulose:

상품명 : 셀코트 L-200, 악조노벨(주)제Product Name: Cellcoat L-200, manufactured by Akzo Nobel Co., Ltd.

(C) 차엑기스(C) tea extract

녹차 추출물, 상품명 「화(和)ism」, 엑기스분 0.2%, 용매 : 50% 부틸렌글리콜 수용액, 마루젠제약(주)제Green tea extract, trade name "Waism", extract content 0.2%, solvent: 50% butylene glycol aqueous solution, manufactured by Maruzen Pharmaceutical Co., Ltd.

(D) 3-옥탄올 시오노향료(주)제(D) 3-octanol Shiono Fragrance Co., Ltd. product

(D) 3-옥틸아세테이트 : (주)이노우에 향료제조소제(D) 3-octyl acetate: manufactured by Inoue Fragrance Manufacturing Co., Ltd.

(D) 3-옥탄온 : (주)이노우에 향료제조소제(D) 3-octanone: manufactured by Inoue Fragrance Manufacturing Co., Ltd.

(D) 펜콘 : 코에이흥업(주)제 또한,(D) Pencon: manufactured by Koei Heung-up Co., Ltd. Also,

사용한 향료A의 조성은 하기와 같다.The composition of the used spice A is as follows.

향료A의 조성 :Composition of perfume A:

카르본 20%Carbon 20%

l-멘톨 66l-menthol 66

메틸부탄알 5Methylbutanal 5

시트로네랄 2Citroneral 2

페릴알데하이드 2Perylaldehyde 2

운데센알 1undecenal 1

리날로올 0.5Linalool 0.5

오렌지유 0.5Orange oil 0.5

에탄올 3ethanol 3

합계 100%Total 100%

[표 1][Table 1]

Figure 112018093828463-pat00001
Figure 112018093828463-pat00001

* ; (C)성분의 배합량은 차엑기스의 순분량을 나타낸다(이하 동일).* ; (C) The compounding quantity of a component shows the pure quantity of tea extract (it is the same hereafter).

[표 2][Table 2]

Figure 112018093828463-pat00002
Figure 112018093828463-pat00002

[표 3][Table 3]

Figure 112018093828463-pat00003
Figure 112018093828463-pat00003

[표 4][Table 4]

Figure 112018093828463-pat00004
Figure 112018093828463-pat00004

[표 5][Table 5]

Figure 112018093828463-pat00005
Figure 112018093828463-pat00005

Claims (7)

(A) 트라넥삼산,
(B) 카티온화셀룰로스 및
(C) 녹차의 친수성 용매 추출물인 차엑기스를 함유하고, [(A)+(B)]/(C)가 질량비로서 0.5∼200, 또한 (B)/(C)가 질량비로서 0.2∼100인 것을 특징으로 하는 구강용 조성물.
(A) tranexamic acid;
(B) cationized cellulose and
(C) contains tea extract, which is a hydrophilic solvent extract of green tea, wherein [(A) + (B)]/(C) is a mass ratio of 0.5 to 200, and (B)/(C) is a mass ratio of 0.2 to 100 Oral composition, characterized in that.
제1항에 있어서,
(B) 카티온화셀룰로스가, 히드록시에틸셀룰로스디메틸디알릴암모늄클로리드인 것을 특징으로 하는 구강용 조성물.
According to claim 1,
(B) A composition for oral cavity characterized in that the cationized cellulose is hydroxyethyl cellulose dimethyldiallylammonium chloride.
제1항 또는 제2항에 있어서,
(A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 용매를 제외한 엑기스 순분으로서 0.0005∼0.2질량% 함유하는 것을 특징으로 하는 구강용 조성물.
According to claim 1 or 2,
The composition for oral cavity characterized by containing 0.01-0.2 mass % of (A) component, 0.01-0.2 mass % of (B) component, and 0.0005-0.2 mass % of (C) component as an extract pure content remove|excluding solvent.
제1항 또는 제2항에 있어서,
또한, (D) 3-옥탄올, 3-옥틸아세테이트, 3-옥탄온 및 펜콘에서 선택되는 1종 이상을 0.0001∼0.1질량% 함유하는 것을 특징으로 하는 구강용 조성물.
According to claim 1 or 2,
Further, (D) a composition for oral cavity characterized by containing 0.0001 to 0.1% by mass of at least one selected from 3-octanol, 3-octyl acetate, 3-octanone and pencon.
제1항 또는 제2항에 있어서,
치마제 또는 세구제인 것을 특징으로 하는 구강용 조성물.
According to claim 1 or 2,
Oral composition, characterized in that the dentifrice or mouthwash.
(A) 트라넥삼산 및 (B) 카티온화셀룰로스를 배합한 구강용 조성물에, (C) 녹차의 친수성 용매 추출물인 차엑기스를 배합하고, [(A)+(B)]/(C)를 질량비로서 0.5∼200, 또한 (B)/(C)를 질량비로서 0.2∼100으로 하는 것을 특징으로 하는 상기 구강용 조성물의 변색 억제 방법.[(A)+(B)]/(C) 0.5 to 200 as mass ratio, and (B)/(C) to 0.2 to 100 as mass ratio, characterized in that the method for suppressing discoloration of the composition for oral cavity. 제6항에 있어서,
(A)성분을 0.01∼0.2질량%, (B)성분을 0.01∼0.2질량%, (C)성분을 용매를 제외한 엑기스 순분으로서 0.0005∼0.2질량% 배합하는 것을 특징으로 하는 상기 구강용 조성물의 변색 억제 방법.
According to claim 6,
0.01 to 0.2% by mass of component (A), 0.01 to 0.2% by mass of component (B), and 0.0005 to 0.2% by mass of component (C) as pure extract excluding the solvent. suppression method.
KR1020180112642A 2017-12-22 2018-09-20 Oral composition and method for inhibiting discoloration thereof KR102531788B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017245754A JP2019112329A (en) 2017-12-22 2017-12-22 Oral cavity composition and discoloration suppression method thereof
JPJP-P-2017-245754 2017-12-22

Publications (2)

Publication Number Publication Date
KR20190076829A KR20190076829A (en) 2019-07-02
KR102531788B1 true KR102531788B1 (en) 2023-05-16

Family

ID=67023301

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180112642A KR102531788B1 (en) 2017-12-22 2018-09-20 Oral composition and method for inhibiting discoloration thereof

Country Status (3)

Country Link
JP (1) JP2019112329A (en)
KR (1) KR102531788B1 (en)
CN (1) CN109953897B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226244A (en) 1999-12-08 2001-08-21 Lion Corp Tooth paste composition
JP2002212042A (en) 2001-01-19 2002-07-31 Pacific Corp Method for producing plant extract powder and composition for oral cavity containing plant extract powder produced by the method
KR100450391B1 (en) 1996-07-03 2005-04-22 주식회사 엘지생활건강 Toothpaste Composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842565B2 (en) 1979-04-27 1983-09-20 株式会社 愛知電機工作所 Switching switch for tap switching device on load
JPS595109A (en) * 1982-06-30 1984-01-12 Lion Corp Composition for oral cavity
JPS60130509A (en) 1983-12-20 1985-07-12 Lion Corp Composition for oral cavity
JP2000297022A (en) * 1999-04-12 2000-10-24 Lion Corp Composition for oral cavity
JP4656299B2 (en) 2004-12-24 2011-03-23 ライオン株式会社 Dentifrice composition and method for preventing discoloration of ε-aminocaproic acid and / or tranexamic acid-containing dentifrice composition
JP5067529B2 (en) 2006-12-13 2012-11-07 ライオン株式会社 Oral composition
JP5007820B2 (en) 2007-12-21 2012-08-22 ライオン株式会社 Dentifrice composition
JP5597969B2 (en) * 2009-11-06 2014-10-01 ライオン株式会社 Dentifrice composition
JP5597970B2 (en) * 2009-11-06 2014-10-01 ライオン株式会社 Dentifrice composition
KR101626471B1 (en) * 2009-11-30 2016-06-01 (주)아모레퍼시픽 Preventive composition of color change for natural pigment
BR112013032266A2 (en) * 2011-06-17 2016-09-06 Unilever Nv oral care composition and use of selected zinc salt

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100450391B1 (en) 1996-07-03 2005-04-22 주식회사 엘지생활건강 Toothpaste Composition
JP2001226244A (en) 1999-12-08 2001-08-21 Lion Corp Tooth paste composition
JP2002212042A (en) 2001-01-19 2002-07-31 Pacific Corp Method for producing plant extract powder and composition for oral cavity containing plant extract powder produced by the method

Also Published As

Publication number Publication date
CN109953897A (en) 2019-07-02
CN109953897B (en) 2023-04-25
JP2019112329A (en) 2019-07-11
KR20190076829A (en) 2019-07-02

Similar Documents

Publication Publication Date Title
RU2355382C2 (en) Zinc-containing oral composition with improved flavour
JP5874383B2 (en) Oral composition
JP5672651B2 (en) Mouthwash composition
JP5310556B2 (en) Oral composition and method for improving astringency of oral composition
JP5397204B2 (en) Oral composition
JP7447470B2 (en) dentifrice composition
KR20110107327A (en) Dentifrice composition
CA2297454A1 (en) Oral and dental hygiene products for sensitive teeth
JP2001031542A (en) Composition for oral cavity
KR102531788B1 (en) Oral composition and method for inhibiting discoloration thereof
JP5825088B2 (en) Liquid oral composition
CN111902125B (en) Oral composition and bitterness improver of alpha-olefin sulfonate
JP2015117215A (en) Dentifrice composition
JP7172028B2 (en) oral composition
JP2010143842A (en) Dentifrice composition
JP2018203714A (en) Oral composition
KR20180133220A (en) Oral composition
JP2007161613A (en) Dentifrice composition
JP2003342142A (en) Composition for oral cavity
JP2001131041A (en) Composition for oral use
KR20200011409A (en) Toothpaste Composition
JP7371351B2 (en) Oral composition
KR20240042359A (en) Dentistry composition
JPH10245328A (en) Tooth powder composition
US20200281831A1 (en) Novel composition

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant